Guideline

Adult antiretroviral therapy guidelines 2014

G. Meintjes
Southern African Journal of HIV Medicine | Vol 15, No 4 | a330 | DOI: https://doi.org/10.4102/sajhivmed.v15i4.330 | © 2014 G. Meintjes | This work is licensed under CC Attribution 4.0
Submitted: 05 January 2014 | Published: 05 January 2014

About the author(s)

G. Meintjes,

Full Text:

PDF (434KB)

Abstract

These guidelines are intended as an update to those published in the Southern African Journal of HIV Medicine in 2012. Since the release of the previous guidelines, the scale-up of antiretroviral therapy (ART) in southern Africa has continued. Cohort studies from the region show excellent clinical outcomes; however, ART is still being initiated late (in advanced disease) in some patients, resulting in relatively high early mortality rates. New data on antiretroviral drugs have become available. Although currently few, there are patients in the region who are failing protease-inhibitor-based second-line regimens. To address this, guidelines on third-line therapy have been expanded.

Please find a link to the update of this guideline: http://sajhivmed.org.za/index.php/hivmed/article/view/428


Keywords

No related keywords in the metadata.

Metrics

Total abstract views: 6195
Total article views: 4812

 

Crossref Citations

1. Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success
Johnny Flippie Daniels, Mohammed Khogali, Erika Mohr, Vivian Cox, Sizulu Moyo, Mary Edginton, Sven Gudmund Hinderaker, Graeme Meintjes, Jennifer Hughes, Virginia De Azevedo, Gilles van Cutsem, Helen Suzanne Cox, Pierre Roques
PLOS ONE  vol: 10  issue: 11  first page: e0142873  year: 2015  
doi: 10.1371/journal.pone.0142873